Xellar Biosystems
PrivateLast Round
Series A
Jun 29, 2026
Total Funding Raised
$73.8M
Company Overview
Xellar Biosystems is a biotechnology company that provides a 3D Bio Intelligence platform combining organ-on-chip systems, laboratory automation, and AI-driven biological modeling to accelerate drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xellar Biosystems Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Xellar Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 29, 2026 | ||||
| Strategic | Apr 30, 2025 | ||||
| Angel | Jul 17, 2024 | ||||
| Seed | Aug 29, 2022 |
Xellar Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series A |
| China Life Investment Management Company | Series A |
| ZhenFund | Seed |
| 国方资本 | Series A |
| Zhengxuan Investment | Angel |
| Tiantu Capital | Strategic, Angel |
| GF Xinde Investment Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2025
Led by XtalPi with participation from Tiantu Capital.
- Aug 29, 2022
$10M round led by Legend Capital
Xellar Biosystems Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xellar Biosystems's valuation, stock price, and market status.